BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17366737)

  • 1. Stereoselective synthesis of L-threo-sphingosine, L-threo-sphinganine, D-threo-sphingosine, and D-threo-sphinganine via oxazoline formation and olefin cross-metathesis; potent protein kinase C inhibitor analogues.
    Tian YS; Joo JE; Pham VT; Lee KY; Ham WH
    Arch Pharm Res; 2007 Feb; 30(2):167-71. PubMed ID: 17366737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient synthesis of D-erythro- and D-threo-sphingosine from D-glucose: olefin cross-metathesis approach.
    Chaudhari VD; Kumar KS; Dhavale DD
    Org Lett; 2005 Dec; 7(26):5805-7. PubMed ID: 16354071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A concise synthesis of a promising protein kinase C inhibitor: D-erythro-sphingosine.
    Pham VT; Joo JE; Tian YS; Oh CY; Ham WH
    Arch Pharm Res; 2007 Jan; 30(1):22-7. PubMed ID: 17328238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
    Yoshimitsu Y; Oishi S; Miyagaki J; Inuki S; Ohno H; Fujii N
    Bioorg Med Chem; 2011 Sep; 19(18):5402-8. PubMed ID: 21868240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A general and concise asymmetric synthesis of sphingosine, safingol and phytosphingosines via tethered aminohydroxylation.
    Kumar P; Dubey A; Puranik VG
    Org Biomol Chem; 2010 Nov; 8(22):5074-86. PubMed ID: 20844791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective synthesis and antiproliferative activity of the isomeric sphinganine analogues.
    Čonková M; Martinková M; Gonda J; Jacková D; Pilátová MB; Kupka D; Jáger D
    Carbohydr Res; 2019 Jan; 472():76-85. PubMed ID: 30529492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective synthesis of C18-guggultetrol and C18-phytosphingosine analogues from D-fructose.
    Ramu Sridhar P; Suresh M; Venu Kumar P; Seshadri K; Venkata Rao C
    Carbohydr Res; 2012 Oct; 360():40-6. PubMed ID: 22975277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Versatile synthetic method for sphingolipids and functionalized sphingosine derivatives via olefin cross metathesis.
    Yamamoto T; Hasegawa H; Hakogi T; Katsumura S
    Org Lett; 2006 Nov; 8(24):5569-72. PubMed ID: 17107074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds.
    Merrill AH; Nimkar S; Menaldino D; Hannun YA; Loomis C; Bell RM; Tyagi SR; Lambeth JD; Stevens VL; Hunter R
    Biochemistry; 1989 Apr; 28(8):3138-45. PubMed ID: 2742830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological properties of novel sphingosine derivatives.
    Murakami T; Furusawa K; Tamai T; Yoshikai K; Nishikawa M
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1115-9. PubMed ID: 15686924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway.
    Coward J; Ambrosini G; Musi E; Truman JP; Haimovitz-Friedman A; Allegood JC; Wang E; Merrill AH; Schwartz GK
    Autophagy; 2009 Feb; 5(2):184-93. PubMed ID: 19098447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective, high-yielding, and stereospecific total synthesis of D-erythro-(2R,3S)-sphingosine from D-ribo-(2S,3S,4R)-phytosphingosine.
    van den Berg RJ; Korevaar CG; Overkleeft HS; van der Marel GA; van Boom JH
    J Org Chem; 2004 Aug; 69(17):5699-704. PubMed ID: 15307742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicomponent cis- and trans-Aziridinatons in the Syntheses of All Four Stereoisomers of Sphinganine.
    Zhou Y; Mukherjee M; Gupta AK; Wulff WD
    Org Lett; 2017 May; 19(9):2230-2233. PubMed ID: 28418256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of threo-4,5-dihydroxy diastereomers of sphinganine;
    Weiss B; Stiller RL
    Chem Phys Lipids; 1975 Feb; 14(1):59-71. PubMed ID: 165009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements of ceramide and sphingosine based inhibitors of mitochondrial ceramidase.
    Usta J; El Bawab S; Roddy P; Szulc ZM; Yusuf ; Hannun A; Bielawska A
    Biochemistry; 2001 Aug; 40(32):9657-68. PubMed ID: 11583166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-yielding synthesis of sphingoid-type bases.
    Séguin C; Ferreira F; Botuha C; Chemla F; Pérez-Luna A
    J Org Chem; 2009 Sep; 74(18):6986-92. PubMed ID: 19673498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine kinase 2 inhibitor SG-12 induces apoptosis via phosphorylation by sphingosine kinase 2.
    Hara-Yokoyama M; Terasawa K; Ichinose S; Watanabe A; Podyma-Inoue KA; Akiyoshi K; Igarashi Y; Yanagishita M
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2220-4. PubMed ID: 23434415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of D-erythro-sphinganine through serine-derived α-amino epoxides.
    Siciliano C; Barattucci A; Bonaccorsi P; Di Gioia ML; Leggio A; Minuti L; Romio E; Temperini A
    J Org Chem; 2014 Jun; 79(11):5320-6. PubMed ID: 24807867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent synthesis of D-erythro-sphingosine, L-threo-sphingosine, and their regioisomers.
    Olofsson B; Somfai P
    J Org Chem; 2003 Mar; 68(6):2514-7. PubMed ID: 12636430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of short-chain sphingoid bases as inhibitors of sphingosine kinase.
    De Jonghe S; Van Overmeire I; Poulton S; Hendrix C; Busson R; Van Calenbergh S; De Keukeleire D; Spiegel S; Herdewijn P
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3175-80. PubMed ID: 10560747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.